Karuna Therapeutics Cash and Cash Equivalents 2011-2026 | KRTX

Annual Cash and Cash Equivalents Karuna Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
186 M	248 M	207 M	53 M	209 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
248 M	53 M	181 M

Quarterly Cash and Cash Equivalents Karuna Therapeutics

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
184 M	264 M	563 M	248 M	628 M	136 M	176 M	207 M	252 M	346 M	354 M	53 M	53 M	53 M	53 M	209 M	209 M	209 M	209 M	8.9 M	8.9 M	8.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
628 M	8.9 M	201 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Alector ALEC	65.8 M	$ 2.11	-13.17 %	$ 217 M	USA
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
Axsome Therapeutics AXSM	323 M	$ 163.89	-	$ 8.15 B	USA
BridgeBio Pharma BBIO	570 M	$ 64.28	-3.31 %	$ 12.3 B	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
BioCardia BCDA	1.1 M	$ 1.37	5.81 %	$ 29 M	USA
AgeX Therapeutics AGE	345 K	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
BioLineRx Ltd. BLRX	10.4 M	$ 2.82	-0.35 %	$ 908 M	Israel
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
BioMarin Pharmaceutical BMRN	1.31 B	$ 59.8	-3.13 %	$ 11.5 B	USA
Bristol-Myers Squibb Company BMY	10.2 B	$ 62.08	-0.46 %	$ 126 B	USA
Benitec Biopharma BNTC	97.7 M	$ 10.93	0.23 %	$ 450 M	USA
BioNTech SE BNTX	9.76 B	$ 109.33	-0.82 %	$ 27.2 B	Germany
Black Diamond Therapeutics BDTX	36.4 M	$ 2.38	-3.44 %	$ 131 M	USA
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
BioXcel Therapeutics BTAI	29.9 M	$ 1.63	-2.4 %	$ 4.13 M	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Burford Capital Limited BUR	322 M	$ 8.65	2.49 %	$ 1.39 B	Britain
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
BeyondSpring BYSI	110 M	$ 1.34	-0.87 %	$ 54 M	USA
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	30 M	-	3.16 %	$ 1.9 M	USA
Cabaletta Bio CABA	193 M	$ 3.34	0.61 %	$ 3.9 M	USA
Aileron Therapeutics ALRN	12.9 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 4.88	2.74 %	$ 10.6 B	Israel
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
Capricor Therapeutics CAPR	14.7 M	$ 27.28	-2.32 %	$ 731 M	USA
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Catalyst Biosciences CBIO	33.5 M	$ 11.67	-3.47 %	$ 768 M	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
C4 Therapeutics CCCC	74.6 M	$ 3.06	13.3 %	$ 254 M	USA
Aptose Biosciences APTO	6.15 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	48.4 M	-	-	$ 269 M	USA
Codexis CDXS	19.3 M	$ 0.99	-2.04 %	$ 72.7 M	USA
Aridis Pharmaceuticals ARDS	4.88 M	-	17.91 %	$ 11.1 M	USA